These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37385413)

  • 1. Effective, but underused: lessons learned implementing contingency management in real-world practice settings in the United States.
    Becker SJ; DiClemente-Bosco K; Rash CJ; Garner BR
    Prev Med; 2023 Nov; 176():107594. PubMed ID: 37385413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial.
    Becker SJ; Murphy CM; Hartzler B; Rash CJ; Janssen T; Roosa M; Madden LM; Garner BR
    Addict Sci Clin Pract; 2021 Oct; 16(1):61. PubMed ID: 34635178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study.
    Becker SJ; Scott K; Murphy CM; Pielech M; Moul SA; Yap KR; Garner BR
    BMC Health Serv Res; 2019 Jul; 19(1):466. PubMed ID: 31288797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial.
    Becker SJ; DiClemente-Bosco K; Scott K; Janssen T; Salino SM; Hasan FN; Yap KR; Garner BR
    Implement Sci; 2023 Sep; 18(1):41. PubMed ID: 37705093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States.
    Parent SC; Peavy KM; Tyutyunnyk D; Hirchak KA; Nauts T; Dura A; Weed L; Barker L; McDonell MG
    Prev Med; 2023 Nov; 176():107614. PubMed ID: 37451553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons Learned in Implementing a Chronic Opioid Therapy Management System.
    Carlile N; Fuller TE; Benneyan JC; Bargal B; Hunt L; Singer S; Schiff GD
    J Patient Saf; 2022 Dec; 18(8):e1142-e1149. PubMed ID: 35617623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.
    Klemperer EM; Evans EA; Rawson R
    Prev Med; 2023 Nov; 176():107647. PubMed ID: 37499918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustainment of Contingency Management within Opioid Treatment Programs: COVID-Related Barriers and Innovative Workflow Adaptations.
    Becker SJ; Bowen CA; Reed EN; Lang S; Correia N; Yermash J; Yap KR; Rash CJ; Garner BR
    Drug Alcohol Depend Rep; 2021 Dec; 1():. PubMed ID: 36277301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When a pandemic and epidemic collide: Lessons learned about how system barriers can interrupt implementation of addiction research.
    Sharp A; Carlson M; Vroom EB; Rigg K; Hills H; Harding C; Moore K; Schuman-Olivier Z
    Implement Res Pract; 2023; 4():26334895231205890. PubMed ID: 37936966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.
    Green B; Parent S; Ware J; Hasson AL; McDonell M; Nauts T; Collins M; Kim F; Rawson R
    J Subst Use Addict Treat; 2023 Aug; 151():209032. PubMed ID: 37061191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment.
    Neale J; Tompkins CN; Strang J
    Addiction; 2016 Apr; 111(4):665-74. PubMed ID: 26498274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with contingency management adoption among opioid treatment providers receiving a comprehensive implementation strategy.
    Becker SJ; Kelly LM; Kang AW; Escobar KI; Squires DD
    Subst Abus; 2019; 40(1):56-60. PubMed ID: 29595403
    [No Abstract]   [Full Text] [Related]  

  • 13. History and current status of contingency management programs in the Department of Veterans Affairs.
    DePhilippis D; Khazanov G; Christofferson DE; Wesley CW; Burden JL; Liberto J; McKay JR
    Prev Med; 2023 Nov; 176():107704. PubMed ID: 37717740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training community-based treatment providers to implement contingency management for opioid addiction: Time to and frequency of adoption.
    Helseth SA; Janssen T; Scott K; Squires DD; Becker SJ
    J Subst Abuse Treat; 2018 Dec; 95():26-34. PubMed ID: 30352667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.